Clinical trial
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1 Receptor Agonists in Chronic Kidney Disease
NCT07309094 is registered in ClinicalTrials.gov with Cardenal Herrera University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1 Receptor Agonists in Chronic Kidney Disease
- Lead sponsor
- Cardenal Herrera University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 15, 2023
- Completion date
- December 31, 2028
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease stage 1, chronic kidney disease stage 2, chronic kidney disease stage3, chronic kidney disease stage4, diabetes mellitus, type 2, obesity